NOT KNOWN FACTS ABOUT NEUROPSYCHOLOGICAL TEST BATTERY FOR DEMENTIA

For the reason that those who carry the APOE e4 gene variant appear to have a bigger threat of serious difficulties, the FDA recommends currently being tested for the gene variant before beginning treatment with lecanemab or donanemab.Have interaction in action. Program routines the individual with dementia enjoys and can do. Dancing, portray, gard